Analysis T Cells Response for Identification of Aspergillus Bronchitis With Cystic Fibrosis Patients
NCT ID: NCT02550041
Last Updated: 2019-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
68 participants
INTERVENTIONAL
2015-09-07
2017-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In addition, the study will evaluate the contribution of biological classification of aspergillosis according to criteria recently proposed by Baxter et al. compared to the classification used in clinical practice in the hospital of Montpellier.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Lung MRI and Allergic Broncho-pulmonary Aspergillosis in Cystic Fibrosis
NCT02853175
Cellular Markers in Treated or Untreated Non-tuberculous Mycobacterial Respiratory Infection in Patients With Cystic Fibrosis
NCT06602869
Epidemiology and Clinical Characteristics of Non-Tuberculous Mycobacteria Infections in Cystic Fibrosis Patients.
NCT03312075
Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
NCT00585364
Immune Profiles in CF Fungal Infection
NCT04476758
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Cystic fibrosis
T specific response for diagnostic of aspergillus bronchitis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
T specific response for diagnostic of aspergillus bronchitis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient aged 15 or over
* Patient able to understand the nature, purpose and methodology of the study.
* Patient and his legal representative for minors who have given their free and informed consent
* Affiliate or beneficiary of a social security scheme.
Exclusion Criteria
* Pregnant or breastfeeding
* Major protected by law (guardianship, curator or under Backup Justice)
* Inability to understand the nature and goals of the study and / or communication difficulties with the investigator
* Subject attending another search including a period of exclusion still going to run-in
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Irmb/U1058
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UF 9582
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.